Several key terms remain open. The share count and price range have not been set, and the registration is not yet effective, so the offering can only be made by prospectus. Valuation estimates vary: one account puts it at $1.5 to $2 trillion, while Bloomberg-sourced reporting says $1.8 to $2 trillion. Timing is also unsettled. Bloomberg reported that formal marketing could begin as early as the week of November 9, which would put trading before Thanksgiving. Axios reported a similar pre-Thanksgiving window, and another outlet points to the week of November 16.
For attorneys, the filing's mission framing is worth reading closely. The company presents its goal of benefiting humanity as contingent on becoming a market leader, which sits uneasily with its February 2026 decision to drop its categorical commitment to halt development, a change it explained by saying it could not count on competitors doing the same. Watch for disclosure disputes over that gap, the governance implications of the dual-class and trust structure, and the accounting treatment behind the loss. An Anthropic listing would also set a valuation benchmark for AI labs, and OpenAI is reportedly weighing its own IPO. Skeptics are already vocal: New Constructs has called it the "most ridiculous IPO of 2026."